Table 1 Patient characteristics (n = 31)
Characteristics | Patients, n | % |
|---|---|---|
Median age (range) | 53 (30–75) | |
Male | 1 | 3.2 |
Female | 30 | 96.8 |
Performance status | ||
0 | 29 | 93.5 |
1 | 2 | 6.5 |
ER/PgR status | ||
Positive/positive | 15 | 48.4 |
Positive/negative | 6 | 19.4 |
Negative/negative | 10 | 32.3 |
No. of metastasis | ||
Median (range) | 3 (1–5) | |
1 | 5 | 16.1 |
2 | 7 | 22.6 |
3 | 15 | 48.4 |
4 | 3 | 9.7 |
5 | 1 | 3.2 |
Site of metastasis | ||
Lymph node | 16 | 51.6 |
Chest wall/skin | 3 | 9.7 |
Lung | 16 | 51.6 |
Pleura | 3 | 9.7 |
Bone | 18 | 58.1 |
Liver | 18 | 58.1 |
Contra late ral breast | 1 | 3.2 |
Muscle | 1 | 3.2 |
Peritoneum | 2 | 6.5 |
No. of prior chemotherapy | ||
Median (range) | 5 (5–8) | |
5 | 19 | 61.3 |
6 | 9 | 29.0 |
7 | 1 | 3.2 |
8 | 2 | 6.5 |
Agent used in prior chemotherapy | ||
CMF | 4 | 12.9 |
Anthracycline | 31 | 100 |
Taxane | 31 | 100 |
Paclitaxel | 11 | 35.5 |
Docetaxel | 26 | 83.9 |
Capecitabine | 31 | 100 |
Vinorelbine | 31 | 100 |
S-1 | 1 | 3.2 |
UFT | 3 | 9.7 |
5-DFUR | 1 | 3.2 |
Other | 1 | 3.2 |